Cargando…

Diffuse cutaneous mastocytosis with novel somatic KIT mutation K509I and association with tuberous sclerosis

Diffuse cutaneous mastocytosis (DCM) is a rare but potentially fatal condition when diagnosis and targeted treatments are delayed. This case illustrates the life‐threatening complications in DCM and reviews the currently available treatments. To our knowledge, this is the first report of mastocytosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otani, Iris M., Carroll, Ryan W., Yager, Phoebe, Kroshinsky, Daniela, Murphy, Sarah, Hornick, Jason L., Akin, Cem, Castells, Mariana, Walter, Jolan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132108/ https://www.ncbi.nlm.nih.gov/pubmed/30214774 http://dx.doi.org/10.1002/ccr3.1607

Ejemplares similares

Clinical presentation and markers of cutaneous versus systemic mastocytosis: the mastocytosis center at brigham and women's hospital in Boston
por: Kanamori, Kelly Yoshimi, et al.
Publicado: (2015)

Well-differentiated systemic mastocytosis with KIT K509I mutation and uterus infiltration in an Asian woman with good response to imatinib
por: Zhao, Duo-Duo, et al.
Publicado: (2019)

Cutaneous mastocytosis in childhood
por: Nemat, Katja, et al.
Publicado: (2022)

Avapritinib for Cutaneous Mastocytosis
por: LEE, Hannah, et al.
Publicado: (2021)

Cutaneous mastocytosis with a mutation in the juxtamembrane domain of c-kit in a young laboratory beagle dog
por: Kato, Yuki, et al.
Publicado: (2015)

Childhood Cutaneous Mastocytosis: Revisited
por: Swarnkar, Bhavya, et al.
Publicado: (2023)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Congenital cutaneous mastocytosis mistaken for non‐accidental injury
por: Porter, Emma, et al.
Publicado: (2023)

Bullous congenital diffuse cutaneous mastocytosis()()
por: Cardoso, Julia Marcon, et al.
Publicado: (2020)

Extensive Cutaneous Mastocytosis After Pregnancy
por: Fris, Eric, et al.
Publicado: (2020)

Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder
por: Chatterjee, Anindya, et al.
Publicado: (2015)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021)

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression
por: Verstovsek, Srdan
Publicado: (2013)

Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors
por: Shomali, William, et al.
Publicado: (2021)

Cutaneous mastocytosis treatment: strategies, limitations and perspectives
por: Czarny, Justyna, et al.
Publicado: (2018)

Cutaneous Mastocytosis in Childhood—Update from the Literature
por: Sandru, Florica, et al.
Publicado: (2021)

Pediatric Cutaneous Mastocytosis With Motor and Intellectual Delay
por: Watanabe, Yusuke, et al.
Publicado: (2023)

Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches
por: Valent, Peter, et al.
Publicado: (2019)

Successful Treatment of Provisional Cutaneous Mastocytosis with Interferon Alpha
por: Rosario, Andrea, et al.
Publicado: (2016)

Primary cutaneous lymphoma in a patient with mastocytosis: Is there an association?
por: Kincaid, Colin M., et al.
Publicado: (2023)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
por: Giannetti, Matthew P., et al.
Publicado: (2021)

Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation
por: Zappulla, Jacques P., et al.
Publicado: (2005)

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
por: Arock, Michel, et al.
Publicado: (2018)

Clinical and molecular categorization of progressive, adult-onset cutaneous mastocytosis
por: Tate, Courtney, et al.
Publicado: (2017)

Unusual presentation of maculopapular cutaneous mastocytosis in an infant with skin of color
por: Markeson, Christopher, et al.
Publicado: (2023)

P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
por: Castells, M., et al.
Publicado: (2022)

Loss of Function of TET2 Cooperates with Constitutively Active KIT in Murine and Human Models of Mastocytosis
por: De Vita, Serena, et al.
Publicado: (2014)

Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy
por: Yang, Min, et al.
Publicado: (2017)

Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis
por: Naumann, Nicole, et al.
Publicado: (2021)

Cutaneous mastocytosis. Getting beneath the skin of the issue: a case report
por: Tamhankar, Parag M, et al.
Publicado: (2009)

Dermoscopic Features of Different Forms of Cutaneous Mastocytosis: A Systematic Review
por: Sławińska, Martyna, et al.
Publicado: (2022)

SAT-509 Sudden Onset of Malabsorption
por: Mroueh, Gabriela, et al.
Publicado: (2020)

New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood
por: CZARNY, Justyna, et al.
Publicado: (2020)

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
por: Valent, Peter, et al.
Publicado: (2023)

Childhood Pityriasis rosea inversa without Herald Patch Mimicking Cutaneous Mastocytosis
por: Ermertcan, Aylin Türel, et al.
Publicado: (2010)

Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab
por: Lieberoth, Sofie, et al.
Publicado: (2015)

Diffuse Cutaneous Mastocytosis with Bullous Lesions and Pulmonary Involvement: A Rare Case
por: Dhar, Sandipan, et al.
Publicado: (2015)

Diffuse cutaneous mastocytosis masquerading as linear IgA bullous dermatosis of childhood
por: Rayinda, Tuntas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19nn0kbc4gbuldd5eam63d6ejm